JRNYS vs MEDVi: Which GLP-1 Program Is Better? (2026)
A detailed side-by-side comparison of JRNYS and MEDVi to help you choose the right GLP-1 weight loss program based on pricing, medications, medical support, and more.
Quick Verdict
We recommend MEDVi
Between these two providers, MEDVi is our pick for most users. It offers a higher overall rating (8.9 vs 6.2), more affordable pricing. That said, JRNYS may be the better fit if you are looking for users willing to pay premium for comprehensive prescription programs.
MEDVi scores 8.9/10 in our independent evaluation at $179/month, while JRNYS scores 6.2/10 at $365/month. Both programs include a licensed physician consultation and ship medication directly to your door. MEDVi also offers oral GLP-1 options for patients who prefer pills over injections. Our rating considers five factors: safety and medical oversight (30%), pricing transparency (25%), cost value (20%), clinical support quality (15%), and onboarding speed (10%). This comparison was independently produced — neither provider pays for placement or higher ratings. Prices verified April 2026.
Side-by-Side Comparison
| Feature | JRNYS | MEDVi |
|---|---|---|
| Monthly Price | $365 | $179 |
| Rating | 6.2 / 10 | 8.9 / 10 |
| Medication Type | Brand-Name Only | Compounded Only |
| Insurance Accepted | No | No |
| States Available | All 50 states | 49 states |
| Consultation Fee | Included | Included |
| Shipping | Free Shipping | Free Shipping |
| Cancel Anytime | Yes | Yes |
| Medical Support | Full medical team | Licensed physicians, unlimited visits, 24/7 messaging |
Prices reflect starting rates without insurance. Actual costs may vary by plan and medication. Last updated April 2026.
JRNYS: Detailed Look
JRNYS
Premium GLP-1 prescription programs
Pros
- Premium prescription-focused program
- FDA-approved medications only
- Full medical team manages your treatment
Cons
- Highest price point at $365/month
- New program — limited reviews and track record available
Users willing to pay premium for comprehensive prescription programs
MEDVi: Detailed Look
MEDVi
Personalized GLP-1 with injectable and oral options from $179
Pros
- Low $179 first-month price includes medication and consultation
- Both injectable and oral dissolving tablet options
- Unlimited doctor visits and 24/7 messaging support
- LegitScript certified for transparency and compliance
Cons
- Refill price jumps to $299/month after the first month
- Cash-pay only — no insurance accepted
Users who want a low entry price with oral and injectable compounded options
Which Should You Choose?
The right choice depends on your specific needs and priorities. Here is a quick decision framework:
Go with MEDVi at $179/month. $179 first month, $299/mo refills — all-inclusive.
MEDVi has the edge with a 8.9 rating.
Choose JRNYS which exclusively prescribes brand-name medications.
MEDVi focuses on compounded medications at a lower price point.
Compare their support: JRNYS offers full medical team, while MEDVi provides licensed physicians, unlimited visits, 24/7 messaging.
JRNYS at $365/month may offer more comprehensive care.
Frequently Asked Questions
Is JRNYS better than MEDVi?
JRNYS has a 6.2 rating while MEDVi has a 8.9 rating. The better choice depends on your priorities — JRNYS is best for users willing to pay premium for comprehensive prescription programs, while MEDVi is best for users who want a low entry price with oral and injectable compounded options.
How much does JRNYS cost compared to MEDVi?
JRNYS starts at $365/month (premium tier with full medical support), while MEDVi starts at $179/month ($179 first month, $299/mo refills — all-inclusive).
Do JRNYS and MEDVi accept insurance?
JRNYS does not accept insurance. MEDVi does not accept insurance.
Which GLP-1 medications does JRNYS offer vs MEDVi?
JRNYS offers Semaglutide, Tirzepatide. MEDVi offers Compounded Semaglutide (Injectable), Compounded Semaglutide (Oral).
Can I cancel JRNYS or MEDVi at any time?
JRNYS allows cancel anytime. MEDVi also allows cancel anytime.
Are JRNYS and MEDVi available in my state?
JRNYS is available in all 50 states. MEDVi is available in 49 states.